This study also challenges the inclusion of several genes frequently present in ARVC panels—foremost among them RYR2. Our results identify genes with definitive and moderate evidence for ARVC and show that most P/LP variants in patients with ARVC occur in these genes. Here, RYR2 is linked to arrhythmogenic right ventricular cardiomyopathy.